Business Context and Reporting Period
Company: Fresenius Medical Care AG & Co. KGaA
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Date: May 3, 2006
Reporting Period: First Quarter 2006
This filing serves as a cover document announcing the release of the Company's first quarter 2006 earnings results via an Investor News release (Exhibit 99.1). The registrant is a German partnership limited by shares.
Key Financial Metrics
The Form 6-K text itself does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These figures are contained within the attached Exhibit 99.1 (Investor News), which is referenced but not included in the provided text.
The filing explicitly identifies the following non-GAAP financial measures used to supplement GAAP results in the attached exhibit:
- EBITDA (Operating income excluding depreciation, amortization, and minority interests)
- Operating income excluding one-time costs
- Free cash flow
- Dialysis products external sales
Material Changes
The filing text does not provide specific data regarding material changes versus the prior comparable period. It notes that the attached Investor News includes reconciliations of non-GAAP measures to GAAP measures to ensure consistency and comparability with prior periods.
Guidance, Outlook, and Risks
Management Commentary: Management states that the non-GAAP measures are provided to enhance the user's understanding of current financial performance and future prospects. They emphasize that these measures should not be used as a substitute for GAAP financial measures.
Risks and Contingencies: The filing includes a standard disclaimer stating that the attached Exhibit 99.1 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and is not subject to the liabilities of that section. It also notes the exhibit is not incorporated by reference in other filings.
Investor Verification Checklist
- Verify the specific Q1 2006 revenue and net income figures in the attached Exhibit 99.1, as they are absent from this cover letter.
- Review the reconciliation tables in Exhibit 99.1 to understand the adjustments made to derive EBITDA and free cash flow from GAAP figures.
- Confirm the impact of "one-time costs" on operating income as detailed in the non-GAAP reconciliation.
- Check the "Dialysis products external sales" metric for insights into the Company's product segment performance.